Somatostatin and Its Receptor System in Colorectal Cancer
Somatostatin (SST)/somatotropin release-inhibiting factor (SRIF) is a well-known neuropeptide, widely distributed in the central and peripheral nervous systems, that regulates the endocrine system and affects neurotransmission via interaction with five SST receptors (SST1-5). In the gastrointestinal...
Main Author: | Aldona Kasprzak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/11/1743 |
Similar Items
-
The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review
by: Aldona Kasprzak, et al.
Published: (2024-03-01) -
The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management
by: Aldona Kasprzak, et al.
Published: (2020-05-01) -
Role of the Ghrelin System in Colorectal Cancer
by: Aldona Kasprzak
Published: (2022-05-01) -
Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment?
by: Christoph Wetz, et al.
Published: (2020-09-01) -
The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia
by: Aldona Kasprzak
Published: (2021-02-01)